ro health glp 1 NEW RESEARCH SHOWS PATIENTS IN BODY MEMBERSHIP LOSE 15.8% OF THEIR BODY WEIGHT ON AVERAGE IN 12 MONTHS It’s a pen. It’s a

This is particularly important when switching from a GLP-1 based therapy to non-GLP-1 options, because the metabolic adjustment can affect blood sugar regulation, blood pressure, and heart rate in ways that warrant monitoring

Above ground pool accidents have led to lawsuits against manufacturers due to defective restraining belts that pose serious safety risks to children

Viomes metatranscriptomic technology allows us to analyze the current gene expression of these microbial pathways

Small handful of nuts as snack

Next-Generation Therapies Shift toward oral GLP-1 pills (no injections) Development of dual and triple agonists (GLP-1 + GIP combinations) Expansion into cardiovascular, kidney, and metabolic diseases 3